Drugs/Pharmaceuticals

Synovics Pharmaceuticals, Inc.’s working capital deficit dropped by 67%, or US$13.12 million, from US$19.45 million at Oct. 31, 2007 to US$6.33 million at Oct. 31, 2008.

The Company reported US$7.16 million…

EpiCept Corporation reports a working capital deficit of US$6.54 million at September 30, 2008 from a US$8.20 million working capital deficit at December 31, 2007.

At September 30, 2008, the Company…